Comparison of Cytochrome P450 2C9 Genotyping Methods and Implications for the Clinical Laboratory
- 1 June 2004
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 24 (6) , 720-726
- https://doi.org/10.1592/phco.24.8.720.36074
Abstract
Study Objective. To compare the accuracy, speed, and cost of two methodologies used for genotyping known variants in the cytochrome P450 (CYP) 2C9 metabolizing enzyme gene. Design. Comparative study....Keywords
This publication has 16 references indexed in Scilit:
- Pharmacogenetics: potential for individualized drug therapy through geneticsTrends in Genetics, 2003
- Welcome to the Genomic EraNew England Journal of Medicine, 2003
- Pharmacogenomics — Drug Disposition, Drug Targets, and Side EffectsNew England Journal of Medicine, 2003
- Inheritance and Drug ResponseNew England Journal of Medicine, 2003
- Single nucleotide polymorphism genotyping: biochemistry, protocol, cost and throughputThe Pharmacogenomics Journal, 2003
- Cytochrome P450 Genotyping by Multiplexed Real-Time DNA Sequencing with Pyrosequencing™ TechnologyASSAY and Drug Development Technologies, 2002
- Collection of Genomic DNA by the Noninvasive Mouthwash Method for Use in Pharmacogenetic StudiesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002
- Clinical relevance of genetic polymorphisms in the human CYP2C subfamilyBritish Journal of Clinical Pharmacology, 2001
- Pyrosequencing Sheds Light on DNA SequencingGenome Research, 2001
- Validation of Methods for CYP2C9 Genotyping: Frequencies of Mutant Alleles in a Swedish PopulationBiochemical and Biophysical Research Communications, 1999